HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: fj.07-101394v1 fj.07-101394v2 22/6/1894    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Puissant, A. Articles by Auberger, P. PubMed PubMed Citation Articles by Puissant, A. Articles by Auberger, P.

Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol

Alexandre Puissant^*,,, Sebastien Grosso^*,,, Arnaud Jacquel^*,,,1, Nathalie Belhacene^*,,, Pascal Colosetti^*,,, Jill-Patrice Cassuto and Patrick Auberger^*,,,2

^* INSERM U526, Nice, France;

Université de Nice Sophia Antipolis, France;

Equipe Labellisée par la Ligue Nationale contre le Cancer; and

Service d’Hématologie Clinique, Centre Hospitalier Universitaire, Nice, France

²Correspondence: INSERM U526, Faculté de Medecine, Avenue de Valombrose, Nice, France 06107 Cedex 2. E-mail: auberger{at}unice.fr

Imatinib is successfully used in the treatment of chronic myelogenous leukemia (CML), and the main mechanisms of resistance in refractory patients are now partially understood. In the present study, we investigated the mechanism of action of resveratrol in imatinib-sensitive (IM-S) and -resistant (IM-R) CML cell lines. Resveratrol induced loss of viability and apoptosis in IM-S and IM-R in a time- and dose-dependent fashion. Inhibition of cell viability was detected for concentrations of resveratrol as low as 5 µM, and the IC₅₀ values for viability, clonogenic assays, apoptosis, and erythroid differentiation were in the 10–25 µM range. The effect of imatinib and resveratrol was additive in IM-S but not in IM-R clones in which the resveratrol effect was already maximal. The effect of resveratrol on apoptosis was partially rescued by zVAD-fmk, suggesting a caspase-independent contribution. Resveratrol action was independent of BCR-ABL expression and phosphorylation, and in agreement was additive to BCR-ABL silencing. Finally, phytoalexin inhibited the growth of BaF3 cells expressing mutant BCR-ABL proteins found in resistant patients, including the multiresistant T315I mutation. Our findings show that resveratrol induces apoptosis, caspase-independent death, and differentiation that collectively contribute to the specific elimination of CML cells. Resveratrol should provide therapeutic benefits in IM-R patients and in other hematopoietic malignancies.—Puissant, A., Grosso, S., Jacquel, A., Belhacene, N., Colosetti, P., Cassuto, J.-P., Auberger, P. Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol.

Key Words: caspase-dependent cell death • caspase-independent cell death • anticancer therapy • BCR-ABL inhibitors